CancerCenter.ai is a Polish-based startup that leverages AI and Deep Learning in cancer diagnosis, specializing in pathology, oncology, and radiology. The company's state-of-the-art technology enables physicians to collaborate in diagnosing cancer more quickly and efficiently without the need for non-digital images.
Utilizing specialized algorithmic solutions, CancerCenter.ai provides rapid access for second and third diagnostic opinions by medical professionals. This not only enhances the efficiency of cancer diagnosis but also reduces the anxiety for both patients and physicians by providing clarity on the nature of the disease.
The company's products, available in both API and Web Platforms, automate image segmentation, identify regions of interest, generate statistical descriptions, count cells and mitosis, and even recognize cell types. This allows doctors to focus on saving lives while CancerCenter.ai concentrates on image processing and fast detection.
Founded in 2017, CancerCenter.ai operates in the Computer Vision and Health Care industries. As of now, there is no publicly disclosed information about the last investment or the investors involved in the recent funding round.